#1 Clinical Trials Search in Europe

Minocycline Hydrochloride

Minocycline Hydrochloride, a tetracycline antibiotic, is being studied in several clinical trials for its potential benefits in treating various medical conditions. These trials aim to evaluate its effectiveness, safety, and mechanisms of action in areas such as periodontal disease, acute ischemic stroke, resistant hypertension, and bioequivalence studies. The research explores different formulations and dosages of minocycline, providing valuable insights into its therapeutic applications beyond its traditional antibiotic use.

Table of Contents

What is Minocycline Hydrochloride?

Minocycline hydrochloride is an antibiotic medication that belongs to the tetracycline class of drugs. It is also known by brand names such as Minocin and Solodyn[1]. Minocycline comes in various forms, including oral capsules, tablets, and extended-release formulations[1].

Medical Uses of Minocycline

Minocycline is used to treat a variety of conditions, including:

  • Periodontitis: This is a severe gum infection that can damage the soft tissue and bone supporting the teeth. Minocycline is used as a local treatment in periodontal pockets to help control the infection[2].
  • Acne: While not explicitly mentioned in the trials, minocycline is commonly prescribed for treating acne.
  • Angelman Syndrome: This is a genetic disorder causing developmental disabilities and neurological problems. Minocycline is being studied as a potential treatment for this condition[3].
  • Acute Ischemic Stroke: Research is ongoing to determine if minocycline can improve outcomes in patients who have suffered from a stroke[4].
  • Resistant Hypertension: Studies are investigating whether minocycline can help lower blood pressure in people whose high blood pressure is resistant to conventional treatments[5].

How Minocycline Works

Minocycline works in different ways depending on the condition being treated:

  • As an antibiotic, it fights bacteria by preventing them from producing proteins essential for their survival[2].
  • In neurological conditions like Angelman Syndrome and stroke, minocycline may have neuroprotective effects. This means it might help protect brain cells from damage[3][4].
  • In hypertension, researchers are exploring whether minocycline affects the gut microbiota (the collection of microorganisms living in our intestines), inflammation, and brain function to lower blood pressure[5].

How Minocycline is Administered

The way minocycline is given depends on the condition being treated:

  • For periodontitis, it may be applied directly into the periodontal pockets (spaces between the teeth and gums)[2].
  • For systemic conditions like Angelman Syndrome, acute ischemic stroke, or hypertension, it is typically taken orally as capsules or tablets. In some cases, it may be given intravenously (through a vein)[3][4][5].
  • Dosages can vary widely. For example, in one study on hypertension, patients took 100 mg twice daily[5], while in a study on Angelman Syndrome, doses ranged from 100 mg to 200 mg per day depending on the patient’s weight[3].

Potential Side Effects

Like all medications, minocycline can cause side effects. Some potential side effects include:

  • Gastrointestinal issues: Such as nausea, vomiting, or diarrhea[3].
  • Skin reactions: Including rashes or increased sensitivity to sunlight[4].
  • Dizziness or vertigo: Some people may experience lightheadedness or a spinning sensation[4].
  • Liver or kidney problems: In rare cases, minocycline can affect liver or kidney function[4].
  • DRESS syndrome: This is a rare but serious allergic reaction that can cause rash, fever, and affect internal organs[4].

It’s important to discuss potential side effects with your healthcare provider and report any unusual symptoms while taking minocycline.

Ongoing Research and Future Potential

Researchers are exploring new uses for minocycline beyond its traditional role as an antibiotic. Some areas of ongoing research include:

  • Neuroprotection in stroke: Studies are investigating whether minocycline can help protect brain cells and improve outcomes in patients who have had a stroke[4].
  • Treatment for Angelman Syndrome: Researchers are studying if minocycline can improve developmental outcomes in children with this genetic disorder[3].
  • Blood pressure control: Scientists are exploring whether minocycline can help lower blood pressure in people with resistant hypertension, possibly by affecting gut bacteria and inflammation[5].
  • New formulations: Researchers are developing and testing new ways to deliver minocycline, such as extended-release capsules, to improve its effectiveness and reduce side effects[1].

These ongoing studies highlight the potential for minocycline to be used in treating a wider range of conditions in the future. However, more research is needed to fully understand its effectiveness and safety in these new applications.

Condition Dosage Administration Duration Primary Outcome Measures
Periodontitis 1 mg Local application in periodontal pockets Up to 6 months Reduction in pocket depth, bacterial load
Acute Ischemic Stroke 200 mg daily Oral or intravenous 21 days Modified Rankin Scale (mRS) at 90 days
Resistant Hypertension 100 mg twice daily Oral 3 months Change in 24-hour systolic blood pressure
Bioequivalence Studies 40-135 mg Oral Single dose Area under the curve (AUC), Peak plasma concentration (Cmax)

FAQ

  • What is Minocycline Hydrochloride used for in these clinical trials? Minocycline Hydrochloride is being studied for various conditions including periodontal disease, acute ischemic stroke, resistant hypertension, and in bioequivalence studies comparing different formulations.
  • How is Minocycline Hydrochloride administered in these trials? The administration varies depending on the study. It can be given orally as capsules or tablets, intravenously, or as a local application in periodontal pockets. Dosages range from 40 mg to 200 mg, and frequency varies from once daily to twice daily.
  • What are some potential benefits of Minocycline Hydrochloride being studied? Potential benefits include reducing pocket depth in periodontal disease, improving neurological outcomes in acute ischemic stroke patients, lowering blood pressure in resistant hypertension, and understanding its effects on gut microbiota and inflammation.
  • Are there any side effects of Minocycline Hydrochloride mentioned in these trials? While specific side effects aren't detailed in most trials, one study mentions monitoring for adverse events such as drug rash, renal dysfunction, photosensitivity, central nervous system effects, and hepatotoxicity.
  • How long do these clinical trials typically last? The duration of the trials varies widely. Some last for a few days for bioequivalence studies, while others can go up to 3 months for studying effects on conditions like resistant hypertension or up to 6 months for periodontal disease studies.

Ongoing Clinical Trials on Minocycline Hydrochloride

  • Study on the Effects of Minocycline on Inflammation in Patients with Depression

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study on Skin Care for Patients with Advanced EGFR-Mutated Lung Cancer Treated with Amivantamab and Lazertinib

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Spain

Glossary

  • Minocycline Hydrochloride: A tetracycline antibiotic used to treat various bacterial infections and being studied for additional therapeutic applications.
  • Bioequivalence: The property of two drug products having the same biological effect and availability in the body when administered at the same dose.
  • Periodontitis: An inflammatory disease affecting the tissues surrounding the teeth, often leading to tooth loss if left untreated.
  • Acute Ischemic Stroke: A sudden interruption in the blood supply to the brain, typically caused by a blood clot, leading to brain tissue damage.
  • Resistant Hypertension: High blood pressure that remains above goal levels despite the use of three or more antihypertensive medications.
  • Modified Rankin Scale (mRS): A scale used to measure the degree of disability or dependence in daily activities of people who have suffered a stroke.
  • National Institute of Health Stroke Scale (NIHSS): A systematic assessment tool that provides a quantitative measure of stroke-related neurologic deficit.
  • Barthel Index: A scale used to measure performance in activities of daily living for patients with neuromuscular or musculoskeletal disorders.
  • Endovascular Thrombectomy: A minimally invasive procedure to remove a blood clot from a blood vessel in the brain in patients with acute ischemic stroke.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body.
  • Extended-Release (ER): A formulation of a drug designed to release the active ingredient slowly over time, maintaining a therapeutic effect for a longer duration.
  • Gut Microbiota: The community of microorganisms living in the digestive tracts of humans and other animals.
  • Neuroinflammation: Inflammation of the nervous tissue, which can be triggered by various factors including infection, injury, or autoimmune reactions.

References

  1. https://clinicaltrials.gov/study/NCT05452785
  2. https://clinicaltrials.gov/study/NCT00662532
  3. https://clinicaltrials.gov/study/NCT02056665
  4. https://clinicaltrials.gov/study/NCT05367362
  5. https://clinicaltrials.gov/study/NCT06246396